GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura.
[Sources: Medcura photo; iStock background; DI Studio]
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
With a new CEO and three seasoned industry veterans joining its board, Research Bridge Partners is focused on moving university innovations from the lab to the marketplace.
Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
Texas Woman’s University Dallas, an offshoot of TWU in Denton, plans to open a campus for its proposed Pioneer College next fall in the burgeoning Y’all Street financial district.
The TWU System Board of Regents recently authorized TWU Dallas to negotiate a lease for 31,000 square feet at 1201 Main St....
The University of Texas at Arlington just unveiled a master plan for its new outpost in west Fort Worth that calls for a 1.6 million-square-foot campus accommodating up to 10,000 students....
Two Austin startups that spun out of Dallas-based de-extinction behemoth Colossal Biosciences are coming together to tackle challenges in designing genetic medicine.
Astromech, an AI company developing models to predict changes in living systems, said today it acquired Form Bio, a business that creates models and tools for designing genetic medicines....
Texas Woman’s University Dallas, an offshoot of TWU in Denton, plans to open a campus for its proposed Pioneer College next fall in the burgeoning Y’all Street financial district.
The TWU System Board of Regents recently authorized TWU Dallas to negotiate a lease for 31,000 square feet at 1201 Main St....
The University of Texas at Arlington just unveiled a master plan for its new outpost in west Fort Worth that calls for a 1.6 million-square-foot campus accommodating up to 10,000 students....
Two Austin startups that spun out of Dallas-based de-extinction behemoth Colossal Biosciences are coming together to tackle challenges in designing genetic medicine.
Astromech, an AI company developing models to predict changes in living systems, said today it acquired Form Bio, a business that creates models and tools for designing genetic medicines....